PMC:6537946 / 20661-21297 JSONTXT

{"project":"0_colil","denotations":[{"id":"31106338-23616602-6307","span":{"begin":123,"end":124},"obj":"23616602"}],"text":"Surgical support in end-stage heart failure, either MCS or a heart transplant, will remain an ongoing topic in cardiology [7]. However, current management is not often guided by the best medical option but rather by feasibility because human donors are ‘limited’ and grafts are scarce. Additionally, a heart transplant requires international coordination, established transplant centres with considerable experience and close collaboration with practicing cardiologists. Because of the scarcity of organs in some areas, there has been a recent structural shift in the indication towards MCS in the management of end-stage heart failure."}

{"project":"TEST0","denotations":[{"id":"31106338-123-128-6307","span":{"begin":123,"end":124},"obj":"[\"23616602\"]"}],"text":"Surgical support in end-stage heart failure, either MCS or a heart transplant, will remain an ongoing topic in cardiology [7]. However, current management is not often guided by the best medical option but rather by feasibility because human donors are ‘limited’ and grafts are scarce. Additionally, a heart transplant requires international coordination, established transplant centres with considerable experience and close collaboration with practicing cardiologists. Because of the scarcity of organs in some areas, there has been a recent structural shift in the indication towards MCS in the management of end-stage heart failure."}

{"project":"2_test","denotations":[{"id":"31106338-23616602-28904620","span":{"begin":123,"end":124},"obj":"23616602"}],"text":"Surgical support in end-stage heart failure, either MCS or a heart transplant, will remain an ongoing topic in cardiology [7]. However, current management is not often guided by the best medical option but rather by feasibility because human donors are ‘limited’ and grafts are scarce. Additionally, a heart transplant requires international coordination, established transplant centres with considerable experience and close collaboration with practicing cardiologists. Because of the scarcity of organs in some areas, there has been a recent structural shift in the indication towards MCS in the management of end-stage heart failure."}

{"project":"MyTest","denotations":[{"id":"31106338-23616602-28904620","span":{"begin":123,"end":124},"obj":"23616602"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Surgical support in end-stage heart failure, either MCS or a heart transplant, will remain an ongoing topic in cardiology [7]. However, current management is not often guided by the best medical option but rather by feasibility because human donors are ‘limited’ and grafts are scarce. Additionally, a heart transplant requires international coordination, established transplant centres with considerable experience and close collaboration with practicing cardiologists. Because of the scarcity of organs in some areas, there has been a recent structural shift in the indication towards MCS in the management of end-stage heart failure."}

{"project":"testtesttest","denotations":[{"id":"T374","span":{"begin":30,"end":35},"obj":"Body_part"},{"id":"T378","span":{"begin":61,"end":66},"obj":"Body_part"},{"id":"T382","span":{"begin":302,"end":307},"obj":"Body_part"},{"id":"T386","span":{"begin":622,"end":627},"obj":"Body_part"}],"attributes":[{"id":"A374","pred":"uberon_id","subj":"T374","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"A375","pred":"uberon_id","subj":"T374","obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"A376","pred":"uberon_id","subj":"T374","obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"A377","pred":"uberon_id","subj":"T374","obj":"http://purl.obolibrary.org/obo/UBERON_0015230"},{"id":"A378","pred":"uberon_id","subj":"T378","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"A379","pred":"uberon_id","subj":"T378","obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"A380","pred":"uberon_id","subj":"T378","obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"A381","pred":"uberon_id","subj":"T378","obj":"http://purl.obolibrary.org/obo/UBERON_0015230"},{"id":"A382","pred":"uberon_id","subj":"T382","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"A383","pred":"uberon_id","subj":"T382","obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"A384","pred":"uberon_id","subj":"T382","obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"A385","pred":"uberon_id","subj":"T382","obj":"http://purl.obolibrary.org/obo/UBERON_0015230"},{"id":"A386","pred":"uberon_id","subj":"T386","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"A387","pred":"uberon_id","subj":"T386","obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"A388","pred":"uberon_id","subj":"T386","obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"A389","pred":"uberon_id","subj":"T386","obj":"http://purl.obolibrary.org/obo/UBERON_0015230"}],"text":"Surgical support in end-stage heart failure, either MCS or a heart transplant, will remain an ongoing topic in cardiology [7]. However, current management is not often guided by the best medical option but rather by feasibility because human donors are ‘limited’ and grafts are scarce. Additionally, a heart transplant requires international coordination, established transplant centres with considerable experience and close collaboration with practicing cardiologists. Because of the scarcity of organs in some areas, there has been a recent structural shift in the indication towards MCS in the management of end-stage heart failure."}